A randomised controlled trial to evaluate the efficacy of a 6 month dietary and physical activity intervention for prostate cancer patients receiving androgen deprivation therapy

Cancer Patients ◽

Controlled Trial ◽

Androgen Deprivation ◽

A randomised controlled trial to evaluate the efficacy of a dietary and physical activity intervention on prostate cancer patients receiving androgen deprivation therapy

Proceedings of The Nutrition Society ◽

10.1017/s0029665112001681 ◽

2012 ◽

Vol 71 (OCE2) ◽

Cited By ~ 2

Author(s):

R. Oneill ◽

L. Murray ◽

J. O'Sullivan ◽

F. Haseen ◽

M. M. Cantwell

Keyword(s):

Physical Activity ◽

Prostate Cancer ◽

Cancer Patients ◽

Controlled Trial ◽

Androgen Deprivation ◽

Preliminary results of a randomised controlled trial to evaluate the efficacy of a dietary and physical activity intervention in prostate cancer patients receiving androgen deprivation therapy

Proceedings of The Nutrition Society ◽

10.1017/s002966511100036x ◽

2011 ◽

Vol 70 (OCE1) ◽

Author(s):

F. Haseen ◽

R. F. O'Neill ◽

L. J. Murray ◽

J. M. O'Sullivan ◽

M. M. Cantwell

Keyword(s):

Physical Activity ◽

Prostate Cancer ◽

Cancer Patients ◽

Controlled Trial ◽

Androgen Deprivation ◽

Preliminary Results ◽

A randomised controlled trial to evaluate the efficacy of a 6-month dietary and physical activity intervention for prostate cancer patients receiving androgen deprivation therapy: midpoint analysis

Proceedings of The Nutrition Society ◽

10.1017/s002966511000220x ◽

2010 ◽

Vol 69 (OCE5) ◽

Author(s):

F. Haseen ◽

L. J. Murray ◽

R. F. O'Neill ◽

J. M. O'Sullivan ◽

M. M. Cantwell

Keyword(s):

Physical Activity ◽

Prostate Cancer ◽

Cancer Patients ◽

Controlled Trial ◽

Androgen Deprivation ◽

A randomised controlled trial to evaluate the efficacy of a 6-month dietary and physical activity intervention for patients receiving androgen deprivation therapy for prostate cancer

Journal of Cancer Survivorship ◽

10.1007/s11764-014-0417-8 ◽

2015 ◽

Vol 9 (3) ◽

pp. 431-440 ◽

Cited By ~ 26

Author(s):

Roisin F. O’Neill ◽

Farhana Haseen ◽

Liam J. Murray ◽

Joe M. O’Sullivan ◽

Marie M. Cantwell

Keyword(s):

Physical Activity ◽

Prostate Cancer ◽

Controlled Trial ◽

Androgen Deprivation ◽

Re: Effects of Different Exercise Modalities on Fatigue in Prostate Cancer Patients Undergoing Androgen Deprivation Therapy: A Year-long Randomised Controlled Trial

The Journal of Urology ◽

10.1016/j.juro.2018.04.021 ◽

2018 ◽

Vol 200 (1) ◽

pp. 10-10

Author(s):

Tomas L. Griebling

Keyword(s):

Prostate Cancer ◽

Cancer Patients ◽

Controlled Trial ◽

Androgen Deprivation ◽

Effects of Different Exercise Modalities on Fatigue in Prostate Cancer Patients Undergoing Androgen Deprivation Therapy: A Year-long Randomised Controlled Trial

European Urology ◽

10.1016/j.eururo.2017.02.019 ◽

2017 ◽

Vol 72 (2) ◽

pp. 293-299 ◽

Cited By ~ 58

Author(s):

Dennis R. Taaffe ◽

Robert U. Newton ◽

Nigel Spry ◽

David Joseph ◽

Suzanne K. Chambers ◽

...

Keyword(s):

Prostate Cancer ◽

Cancer Patients ◽

Controlled Trial ◽

Androgen Deprivation ◽

Can supervised exercise prevent treatment toxicity in patients with prostate cancer initiating androgen-deprivation therapy: a randomised controlled trial

BJU International ◽

10.1111/bju.12646 ◽

2014 ◽

Vol 115 (2) ◽

pp. 256-266 ◽

Cited By ~ 122

Author(s):

Prue Cormie ◽

Daniel A. Galvão ◽

Nigel Spry ◽

David Joseph ◽

Raphael Chee ◽

...

Keyword(s):

Prostate Cancer ◽

Controlled Trial ◽

Androgen Deprivation ◽

Treatment Toxicity ◽

Supervised Exercise ◽

Feasibility study of a randomised controlled trial to compare (deferred) androgen deprivation therapy and cryotherapy in men with localised radiation-recurrent prostate cancer

British Journal of Cancer ◽

10.1038/bjc.2014.316 ◽

2014 ◽

Vol 111 (3) ◽

pp. 424-429 ◽

Cited By ~ 11

Author(s):

M Salji ◽

◽

R Jones ◽

J Paul ◽

F Birrell ◽

...

Keyword(s):

Prostate Cancer ◽

Feasibility Study ◽

Controlled Trial ◽

Androgen Deprivation ◽

Recurrent Prostate Cancer ◽

Re: Androgen Deprivation Therapy plus Docetaxel and Estramustine Versus Androgen Deprivation Therapy Alone for High-risk Localised Prostate Cancer (GETUG 12): A Phase 3 Randomised Controlled Trial

European Urology ◽

10.1016/j.eururo.2015.08.047 ◽

2015 ◽

Vol 68 (6) ◽

pp. 1098-1099

Author(s):

Giuseppe Di Lorenzo ◽

Riccardo Autorino ◽

Guru Sonpavde

Keyword(s):

Prostate Cancer ◽

High Risk ◽

Controlled Trial ◽

Androgen Deprivation ◽

Phase 3 ◽

Androgen deprivation therapy plus docetaxel and estramustine versus androgen deprivation therapy alone for high-risk localised prostate cancer (GETUG 12): a phase 3 randomised controlled trial

The Lancet Oncology ◽

10.1016/s1470-2045(15)00011-x ◽

2015 ◽

Vol 16 (7) ◽

pp. 787-794 ◽

Cited By ~ 139

Author(s):

Karim Fizazi ◽

Laura Faivre ◽

François Lesaunier ◽

Remy Delva ◽

Gwenaëlle Gravis ◽

...

Keyword(s):

Prostate Cancer ◽

High Risk ◽

Controlled Trial ◽

Androgen Deprivation ◽

Phase 3 ◽